Okey Stephanie — SEC insider filings

SEC reporting owner CIK 1742616. 30 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-12-10 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PTC THERAPEUTICS, INC. (PTCT)Director13—7 legs · 31,133 sh · $1,960,64517
Crinetics Pharmaceuticals, Inc. (CRNX)Director10—4 legs · 27,400 sh · $1,176,80321
ALBIREO PHARMA, INC. (ALBO)Director3——8
Catalent, Inc. (CTLT)Director4——4

Insider filings — Okey Stephanie

FiledFormIssuerReported transactionsSource
2026-09-014Crinetics Pharmaceuticals, Inc. (CRNX)Disposition to issuer (D): 6,400 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 25,000 (derivative) @ $60.85 · Disposition to issuer (D): 12,500 (derivative) @ $61.77 · Disposition to issuer (D): 17,500 (derivative) @ $64.77 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · +3 moreEDGAR
2026-06-224Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0EDGAR
2026-06-184Crinetics Pharmaceuticals, Inc. (CRNX)Sale (S): 6,292 @ $35.62 · Sale (S): 608 @ $36.22EDGAR
2026-03-124PTC THERAPEUTICS, INC. (PTCT)Option exercise (M): 1,167 @ $33.63 · Sale (S): 1,167 @ $70 · Option exercise (M): 14,000 @ $33.63 · Sale (S): 14,000 @ $70 · Option exercise (M): 1,167 (derivative) @ $0 · Option exercise (M): 14,000 (derivative) @ $0EDGAR
2026-03-094PTC THERAPEUTICS, INC. (PTCT)Sale (S): 6,333 @ $63.38EDGAR
2026-03-044Crinetics Pharmaceuticals, Inc. (CRNX)Sale (S): 3,000 @ $39.67EDGAR
2026-01-064PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0EDGAR
2025-11-214PTC THERAPEUTICS, INC. (PTCT)Gift (G): 867 @ $0EDGAR
2025-06-134Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0EDGAR
2025-03-174PTC THERAPEUTICS, INC. (PTCT)Sale (S): 5,000 @ $54EDGAR
2025-01-074PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0EDGAR
2024-12-184Catalent, Inc. (CTLT)Disposition to issuer (D): 12,635EDGAR
2024-11-014Catalent, Inc. (CTLT)Grant/award (A): 4,663 @ $0EDGAR
2024-06-114Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-04-024Crinetics Pharmaceuticals, Inc. (CRNX)Option exercise (M): 17,500 @ $18.29 · Sale (S): 17,500 @ $46.38 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2024-02-164PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-10-314Catalent, Inc. (CTLT)Grant/award (A): 6,993 @ $0EDGAR
2023-08-304Catalent, Inc. (CTLT)Grant/award (A): 979 @ $0EDGAR
2023-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 6,000 @ $0 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-03-024ALBIREO PHARMA, INC. (ALBO)Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 11,000 (derivative)EDGAR
2023-01-094PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-08-114PTC THERAPEUTICS, INC. (PTCT)Sale (S): 2,296 @ $51.62EDGAR
2022-06-284ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2022-06-214Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-01-114PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 3,200 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-08-174PTC THERAPEUTICS, INC. (PTCT)Sale (S): 1,650 @ $40.06EDGAR
2021-06-284ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2021-06-234Crinetics Pharmaceuticals, Inc. (CRNX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-01-084PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 1,650 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2020-12-104PTC THERAPEUTICS, INC. (PTCT)Sale (S): 687 @ $62.52EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742616 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs